September 23, 2017 1:13 PM ET

Healthcare Providers and Services

Company Overview of Quest Diagnostics Incorporated

Company Overview

Quest Diagnostics Incorporated provides diagnostic testing information and services in the United States and internationally. The company’s Diagnostic Information Services business segment develops and delivers diagnostic testing information and services, such as routine testing, gene-based and esoteric testing, and drugs-of-abuse testing, as well as anatomic pathology services, and related services and insights. This segment offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum, and Care360 brands to patients, clinicians, hospitals, integrated delivery n...

3 Giralda Farms

Madison, NJ 07940

United States

Founded in 1967

43,000 Employees

Phone:

973-520-2700

Key Executives for Quest Diagnostics Incorporated

Chairman, Chief Executive Officer and President
Age: 60
Total Annual Compensation: $1.1M
Chief Financial Officer and Executive Vice President
Age: 55
Total Annual Compensation: $586.5K
Executive Vice President of General Diagnostics
Age: 54
Total Annual Compensation: $586.5K
Senior Vice President and Group Executive of Clinical Franchise Solutions & Marketing
Age: 54
Total Annual Compensation: $575.0K
Senior Vice President and Group Executive of Diagnostic Solutions
Age: 62
Total Annual Compensation: $575.0K
Compensation as of Fiscal Year 2016.

Quest Diagnostics Incorporated Key Developments

Quest Diagnostics Incorporated Presents at Morgan Stanley 15th Annual Global Healthcare Conference, Sep-12-2017 10:35 AM

Quest Diagnostics Incorporated Presents at Morgan Stanley 15th Annual Global Healthcare Conference, Sep-12-2017 10:35 AM. Venue: Grand Hyatt New York, 109 E. 42nd Street, New York, New York, United States. Speakers: Mark J. Guinan, Chief Financial Officer and Executive Vice President, Stephen H. Rusckowski, Chairman, Chief Executive Officer and President.

Quest Diagnostics Declares Quarterly Cash Dividend, Payable on October 18, 2017

Quest Diagnostics announced that its Board of Directors declared a quarterly cash dividend of $0.45 per share, payable on October 18, 2017 to shareholders of record of company's common stock on October 3, 2017.

Quest Diagnostics Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2017; Revises Earnings Guidance for the Year 2017

Quest Diagnostics Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2017. For the quarter, net revenues were $1,943 million against $1,906 million a year ago. Operating income was $319 million against $422 million a year ago. Income before income taxes and equity in earnings of equity method investees was $292 million against $383 million a year ago. Net income attributable to the company was $193 million against $195 million a year ago. Earnings per share attributable to the company’s common stockholders – diluted were $1.37 against $1.37 a year ago. Adjusted operating income was $343 million against $324 million a year ago. Adjusted net income was $204 million against $178 million a year ago. Adjusted diluted EPS excluding amortization expense were $1.55 against $1.34 a year ago. For six months, net revenues were $3,842 million against $3,769 million a year ago. Operating income was $598 million against $679 million a year ago. Income before income taxes and equity in earnings of equity method investees was $538 million against $555 million a year ago. Net income attributable to the company was $357 million against $298 million a year ago. Earnings per share attributable to the company’s common stockholders – diluted were $2.53 against $2.08 a year ago. Net cash provided by operating activities was $490 million against $464 million a year ago. Capital expenditures were $107 million against $104 million a year ago. Adjusted operating income was $640 million against $605 million a year ago. Adjusted net income was $379 million against $327 million a year ago. Adjusted diluted EPS excluding amortization expense were $2.88 against $2.47 a year ago. For the year 2017, the company expects revenue to be in the range of $7.69 billion to $7.74 billion compared to $7.64 billion to $7.72 billion as previously forecasted, diluted earnings per share to be in the range of $4.90 to $5.00 compared to $4.73 to $4.88 as previously forecasted, adjusted earnings per share to be in the range of $5.62 $5.72 compared to $5.45 to $5.60 as previously forecasted, capital expenditures to be in the range of $250 million to $300 million and cash provided by operations to be at approx. $1.2 billion compared to $1.1 billion as previously forecasted.

Similar Private Companies By Industry

Company Name Region
@ Home Medical, Inc. United States
@home approach, llc United States
@Home Care United States
1011 E. Pecan Grove Road, LLC United States
1104 Welsh Road Operations LLC United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
June 27, 2017
Cape Cod Healthcare, Inc., Laboratory Services Business
Merger/Acquisition
June 12, 2017
Med Fusion LLC
Merger/Acquisition
June 12, 2017
ClearPoint Diagnostic Laboratories, LLC
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Tax Management Inc United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Quest Diagnostics Incorporated, please visit www.questdiagnostics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.